Cancer Services Trials Unit - Dr Hannah Rose
I graduated with honours from Monash University Melbourne in 1998 and completed advanced training in Haematology through the Austin Hospital Melbourne and University Hospital Geelong.
I have worked as a consultant haematologist at University Hospital Geelong since 2013 where I treat patients with all types of blood and bone marrow cancers, as well as clotting and bleeding disorders.
I am actively involved in clinical research in the area of blood and bone marrow cancers, particularly lymphoma and am the co-lead of the Lymphoma clinical trials portfolio at Barwon Health. I am currently the principal investigator of clinical trials for patients with Hodgkin lymphoma and non-Hodgkin Lymphomas, including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma and chronic lymphocytic leukaemia. I am a sub-investigator on many other trials for patients with myeloma, acute leukaemia, myelodysplasia and aplastic anaemia.
- Constantine S, Hannah Rose, et al. Zanubrutinib plus obinutuzumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or relapsed/refractory (R/R) follicular lymphoma (FL). Blood Advances 2020
- Aileen Cohen et al . GB-3111-302 ASPEN Phase 3 head to head trial of Zanubrutinib and Ibrutinib for Waldenstrom’s Macroglobulinemia. Primary Analysis Results, , personal communication Dec 2019. To be submitted for publication 2020
- D Wong, H Rose, P Campbell. Microangiopathic haemolytic anaemia in metastatic renal cell carcinoma: a tale of two distinct pathologies. Internal Medicine Journal 2020: 768-69
- J Er, H Rose, D Routledge, D Kipp, H Fairweather, A Friebe, J Hempton, P Campbell. Efficacy and Safety of Autologous Stem Cell Transplantion (ASCT) in elderly Multiple Myeloma patients aged >65 years: a single centre experience. Poster abstract at European Haematology Association Scientific Meeting, Stockholm, June 2018
How you can help
Participate in a Clinical Trial
Research requires ongoing investment and there are several ways to support our work. You can make a donation today and contribute to an item on our research group’s wish list, consider a bequest in your will, or establish a lasting legacy fund in your name. No matter what size, your philanthropic support will deliver an immediate impact to this important work. To donate now or for more information, please contact the Barwon Health Foundation.
Last Modified: Monday, 26 September 2022